WOLFGANG GEORG KONRAD MÜLLER-LIERHEIM,GYSBERT-BOTHO VAN SETTEN
申请号：
US17048451
公开号：
US20210077523A1
申请日:
2019.04.17
申请国别(地区):
US
年份:
2021
代理人:
摘要：
The invention concerns a method for reducing, preventing, or delaying the onset of severe ocular surface disease, or preventing or delaying the progression of mild or moderate ocular surface disease to severe ocular surface disease, by topically administering a fluid comprising high molecular weight hyaluronic acid to the ocular surface of the eye of a human or non-human animal subject, wherein the hyaluronic acid has an intrinsic viscosity of >2.5 m3/kg and a concentration of <0.2% w/v.
